Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin.
Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JI.
Hypertension. 2009 Dec;54(6):1313-1320. Epub 2009 Nov 2.PMID: 19884563 [PubMed - as supplied by publisher]Related articles